Inhibition of Aerobic Glycolysis in Yoshida Ascites Hepatoma by Tartronic Acid

Article metrics


THE inhibition of lactic dehydrogenase should allow a blocking of aerobic glycolysis of neoplastic cells, thus depriving them of a high percentage of adenosine triphosphate without damaging the normal cells which, in conditions of normal functional activity and sufficient oxygen supply, do not need this enzyme1. According to this premise, the action of tartronic acid, which is a lactic dehydrogenase inhibitor2,3, on the growth of Yoshida's ascites hepatoma and Ehrlich's ascites tumour was studied1.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Fiume, L., Boll. Soc. Ital. Biol. Sper., 34, 434 (1958).

  2. 2

    Quastel, J. H., and Wooldridge, W. R., Biochem. J., 22, 689 (1928).

  3. 3

    Fiume, L., and Reggianini, O., Boll. Soc. Ital. Biol. Sper., 33, 234 (1957).

  4. 4

    Barker, S. B., and Summerson, W. H., J. Biol. Chem., 138, 535 (1941).

  5. 5

    Le Page, G. A., in “Manometric Techniques”, edit. by Umbreit, W. W., Burris, R. H., and Stauffer, J. F., 104 (Burgess, Minneapolis, 1948).

  6. 6

    Bak, B., Ann. Chem., 537, 286 (1939).

  7. 7

    Rieben, W. R., and Hastings, A. B., Helvetica Physiol. et Pharmacol. Acta, 4, C, 52 (1946).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

FIUME, L. Inhibition of Aerobic Glycolysis in Yoshida Ascites Hepatoma by Tartronic Acid. Nature 187, 792–793 (1960) doi:10.1038/187792a0

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.